Search

everythinglearnresearchcommunity

for

Search:↓

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

PRP therapy may help with ovarian issues and fertility, but more research is needed.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Men and premenopausal women in Korea show different patterns in iron and vitamin D levels, with no clear pattern for postmenopausal women.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Finasteride works for male hair loss only.

Ancient hair can preserve hormones, revealing health and fertility insights.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Hair transplantation is the only permanent solution for female pattern hair loss and can greatly improve quality of life with careful planning.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.